AstraZeneca Daily Pill Effectively Reduces Lung Cancer Deaths in Half, According to Large Clinical Trial Medicine & Technology Jun 09, 2023 Deaths of lung cancer patients were reduced in half by a once-daily pill made by AstraZeneca. Read the article to find out more.
FDA Grants Approval To AstraZeneca's New Lung Cancer Pill Nov 16, 2015 The Food and Drug Administration (FDA) recently approved a new lung cancer pill, called AZD9291 or Tagrisso, from AstraZeneca after its two-year clinical trial with promising results.
Pharaoh's Curse Unlocked? Scientists Claim To Have Cracked the Mystery of What Killed Over 20 People Who Opened the Tomb of King Tut in 1922
SPACE NASA’s TESS Mission Spots Its First Free-Floating Planet Using ‘Rogue-Hunting’ Concept From Einstein
SPACE ‘Morbid’ Alien Theory: Extraterrestrials Haven’t Contacted Humans As They’re Destroyed by Gamma-Ray Bursts